Rege Nephro Co
Developing innovative therapies and medical technologies for patients with kidney diseases who currently have limited treatment options
$10.6MSeries C
Role not disclosedBV
BA7 Venture Capital CORP
Activity from announced rounds
Activity in this selectionin-venture-c5099549
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $10.6M 1 disclosed · full round size, not this investor’s share